Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial
- PMID: 28466151
- DOI: 10.1007/s00134-017-4782-4
Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial
Abstract
Purpose: Guidelines recommend administering antibiotics within 1 h of sepsis recognition but this recommendation remains untested by randomized trials. This trial was set up to investigate whether survival is improved by reducing the time before initiation of antimicrobial therapy by means of a multifaceted intervention in compliance with guideline recommendations.
Methods: The MEDUSA study, a prospective multicenter cluster-randomized trial, was conducted from July 2011 to July 2013 in 40 German hospitals. Hospitals were randomly allocated to receive conventional continuous medical education (CME) measures (control group) or multifaceted interventions including local quality improvement teams, educational outreach, audit, feedback, and reminders. We included 4183 patients with severe sepsis or septic shock in an intention-to-treat analysis comparing the multifaceted intervention (n = 2596) with conventional CME (n = 1587). The primary outcome was 28-day mortality.
Results: The 28-day mortality was 35.1% (883 of 2596 patients) in the intervention group and 26.7% (403 of 1587 patients; p = 0.01) in the control group. The intervention was not a risk factor for mortality, since this difference was present from the beginning of the study and remained unaffected by the intervention. Median time to antimicrobial therapy was 1.5 h (interquartile range 0.1-4.9 h) in the intervention group and 2.0 h (0.4-5.9 h; p = 0.41) in the control group. The risk of death increased by 2% per hour delay of antimicrobial therapy and 1% per hour delay of source control, independent of group assignment.
Conclusions: Delay in antimicrobial therapy and source control was associated with increased mortality but the multifaceted approach was unable to change time to antimicrobial therapy in this setting and did not affect survival.
Keywords: Antimicrobial agents; Critical illness; Quality improvement; Septic shock/drug therapy.
Comment in
-
Is it time to implement door-to-needle time for "infection attacks"?Intensive Care Med. 2017 Nov;43(11):1712-1713. doi: 10.1007/s00134-017-4797-x. Epub 2017 May 2. Intensive Care Med. 2017. PMID: 28466150 No abstract available.
Similar articles
-
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.JAMA Intern Med. 2016 Sep 1;176(9):1266-76. doi: 10.1001/jamainternmed.2016.2514. JAMA Intern Med. 2016. PMID: 27428731 Clinical Trial.
-
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain.JAMA. 2008 May 21;299(19):2294-303. doi: 10.1001/jama.299.19.2294. JAMA. 2008. PMID: 18492971
-
Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program.Crit Care Med. 2014 Aug;42(8):1749-55. doi: 10.1097/CCM.0000000000000330. Crit Care Med. 2014. PMID: 24717459
-
Does Early and Appropriate Antibiotic Administration Improve Mortality in Emergency Department Patients with Severe Sepsis or Septic Shock?J Emerg Med. 2017 Oct;53(4):588-595. doi: 10.1016/j.jemermed.2016.12.009. Epub 2017 Sep 12. J Emerg Med. 2017. PMID: 28916120 Review.
-
[First-line anti-infective treatment in sepsis].Med Klin Intensivmed Notfmed. 2014 Nov;109(8):577-82. doi: 10.1007/s00063-014-0378-8. Epub 2014 Oct 26. Med Klin Intensivmed Notfmed. 2014. PMID: 25344412 Review. German.
Cited by
-
A cytokine/PTX3 prognostic index as a predictor of mortality in sepsis.Front Immunol. 2022 Sep 15;13:979232. doi: 10.3389/fimmu.2022.979232. eCollection 2022. Front Immunol. 2022. PMID: 36189302 Free PMC article.
-
Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.Crit Care. 2018 Sep 24;22(1):233. doi: 10.1186/s13054-018-2155-1. Crit Care. 2018. PMID: 30244674 Free PMC article. Review.
-
Blood virome of patients with traumatic sepsis.Virol J. 2023 Sep 1;20(1):198. doi: 10.1186/s12985-023-02162-4. Virol J. 2023. PMID: 37658428 Free PMC article.
-
[Urosepsis].Med Klin Intensivmed Notfmed. 2018 Mar;113(2):143-156. doi: 10.1007/s00063-018-0406-1. Med Klin Intensivmed Notfmed. 2018. PMID: 29442147 German.
-
Prolonged Infusion of β-Lactams Decreases Mortality in Patients with Septic Shock: A Retrospective before-and-after Study.Antibiotics (Basel). 2021 Jun 8;10(6):687. doi: 10.3390/antibiotics10060687. Antibiotics (Basel). 2021. PMID: 34201244 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical